Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR4 | P22455 | 11/20 | 0.45 |
| ▸ | RPS6KB2 | Q9UBS0 | 2/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | FGFR2 | P21802 | 3/20 | 0.38 |
| ▸ | FGFR3 | P22607 | 3/20 | 0.38 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.34 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CSF1R | P07333 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15412876 | 0.95 | FGFR4 (0.49) | FGFR4RPS6KB2FGFR1FGFR2FGFR3 | |
| SCHEMBL15412842 | 0.79 | FGFR1 (0.65) | FGFR4RPS6KB2FGFR1FGFR2FGFR3 | |
| SCHEMBL15434002 | 0.79 | FGFR4 (0.49) | FGFR4RPS6KB2FGFR1FGFR2FGFR3 | |
| SCHEMBL15413174 | 0.73 | FGFR4 (0.78) | FGFR4FGFR1FGFR2FGFR3CYP1A2 | |
| SCHEMBL15413168 | 0.73 | FGFR4 (0.60) | FGFR4RPS6KB2FGFR1KMT2AMEN1 | |
| SCHEMBL15413317 | 0.70 | FGFR4 (0.73) | FGFR4RPS6KB2FGFR1FGFR2FGFR3 | |
| SCHEMBL15854324 | 0.68 | FGFR1 (0.52) | FGFR4RPS6KB2FGFR1FGFR2FGFR3 | |
| SCHEMBL24335312 | 0.68 | CYP11B1 (0.44) | FGFR1MAPTFGFR2FGFR3SMN1; SMN2 | |
| SCHEMBL18612934 | 0.68 | FGFR4 (0.41) | FGFR4RPS6KB2FGFR1KMT2AMEN1 | |
| SCHEMBL18134016 | 0.68 | TSHR (0.47) | KMT2AMEN1MAPTCYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170066812-A1 | INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR | BLUEPRINT MEDICINES CORPORATION | 2017-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170066812-A1 | INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR | FGFR1, FGFR2, FGFR3 | FGFR4 5/4885RPS6KB2 370/4885FGFR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.